ArticleCancer drug resistance (Alhambra, Calif.)2022
Improving HER2 testing reproducibility in HER2-low breast cancer.
Elham Sajjadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
ArticleCancer drug resistance (Alhambra, Calif.)2022
Elham Sajjadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.